Replies to post #863 on Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[ash111]

yes.steady move on both tase and nasdaq

[ash111]

Wait when updates hits,a few millions float(adrs),everyone will be chasing imo. cap($12m),market potential ( blockbuster potential as mentioned by analyst ), 2 upcoming milestone soon (Q1),no debt, no need to raise cash due P3 declared final and target was fully achieved, trading above MA50.Drug, same celebrex($1.8B sales/year) but without its risks. KTOV is a winner.Analysts just start to realize it (IPO'd a couple months ago).